- Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
- Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
- Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
- Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
More ▼
Key statistics
On Monday, Conduit Pharmaceuticals Inc (CDT:NMQ) closed at 3.34, 251.58% above the 52 week low of 0.95 set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.13 |
---|---|
High | 3.34 |
Low | 3.10 |
Bid | 2.45 |
Offer | 3.50 |
Previous close | 3.34 |
Average volume | 16.09k |
---|---|
Shares outstanding | 73.83m |
Free float | 7.03m |
P/E (TTM) | -- |
Market cap | 246.59m USD |
EPS (TTM) | -0.0031 USD |
Data delayed at least 15 minutes, as of Apr 29 2024 21:00 BST.
More ▼